Human Atopic Dermatitis Skin-derived T Cells can Induce a Reaction in Mouse Keratinocytes in vivo

Scandinavian Journal of Immunology

Volumn 82, Issue 2, 2015, Pages 125-134

  Martel, B C ^a,b,c   Blom, L ^a   Dyring Andersen, B ^a   Skov, L ^a   Thestrup Pedersen, K ^a   Skov, S ^b   Skak, K ^c   Poulsen, L K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LEO PHARMA A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; KI 67 ANTIGEN; CALGRANULIN A; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CD4 CD8 RATIO; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL TRANSFER; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; DISEASE COURSE; ECZEMA; EPIDERMIS; ERYTHEMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KERATINOCYTE; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN; SKIN EDEMA; SKIN MANIFESTATION; SKINFOLD THICKNESS; SUBCUTANEOUS TISSUE; T CELL CULTURE; T LYMPHOCYTE; TH2 CELL; YOUNG ADULT; ANIMAL; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; FEMALE; IMMUNOLOGY; LYMPHOCYTE COUNT; NONOBESE DIABETIC MOUSE; SCID MOUSE; TRANSPLANTATION; XENOGRAFT;

ADULT; ANIMALS; CALGRANULIN A; CD4-CD8 RATIO; CELL MOVEMENT; CELL PROLIFERATION; DERMATITIS, ATOPIC; ECZEMA; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-2; INTERLEUKIN-4; KERATINOCYTES; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; SKIN; TH2 CELLS; TRANSPLANTATION, HETEROLOGOUS; YOUNG ADULT;

EID: 84936075971     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12316     Document Type: Article

References (31)

1. Homey B, Steinhoff M, Ruzicka T, Leung DY. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006;118:178-89.
2. Kawakami T, Ando T, Kimura M, Wilson BS, Kawakami Y. Mast cells in atopic dermatitis. Curr Opin Immunol 2009;21:666-78.
3. Werfel T. The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 2009;129:1878-91.
4. Matsuda H, Watanabe N, Geba GP et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997;9:461-6.
5. Andrade D, Redecha PB, Vukelic M et al. Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rgamma-/- mice: a promising model for studying human disease. Arthritis Rheum 2011;63:2764-73.
6. Davis LS, Sackler M, Brezinschek RI et al. Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis. Am J Pathol 2002;160:357-67.
7. Nolte T, Zadeh-Khorasani M, Safarov O et al. Induction of oxazolone-mediated features of atopic dermatitis in NOD-scid IL2Rgamma(null) mice engrafted with human peripheral blood mononuclear cells. Dis Model Mech 2013;6:125-34.
8. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980;92:44-7.
9. Blom L, Poulsen LK. In vitro Th1 and Th2 cell polarization is severely influenced by the initial ratio of naive and memory CD4 + T cells. J Immunol Methods 2013;397:55-60.
10. Ito M, Hiramatsu H, Kobayashi K et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002;100:3175-82.
11. Hijnen D, De Bruin-Weller M, Oosting B et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004;113:334-40.
12. Kakinuma T, Nakamura K, Wakugawa M et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-41.
13. Niwa Y. Elevated RANTES levels in plasma or skin and decreased plasma IL-10 levels in subsets of patients with severe atopic dermatitis. Arch Dermatol 2000;136:125-6.
14. de Jongh GJ, Zeeuwen PL, Kucharekova M et al. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 2005;125:1163-73.
15. Khattri S, Shemer A, Rozenblit M et al. Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. J Allergy Clin Immunol 2014;133:1626-34.
16. Gittler JK, Shemer A, Suarez-Farinas M et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 2012;130:1344-54.
17. Kamsteeg M, Bergers M, de Boer R et al. Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent. Am J Pathol 2011;178:2091-9.
18. Howell MD, Kim BE, Gao P et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007;120:150-5.
19. Campbell HD, Tucker WQ, Hort Y et al. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc Natl Acad Sci USA 1987;84:6629-33.
20. de Vries JE. Molecular and biological characteristics of interleukin-13. Chem Immunol 1996;63:204-18.
21. McKenzie AN, Culpepper JA, de Waal MR et al. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993;90:3735-9.
22. Park LS, Friend D, Sassenfeld HM, Urdal DL. Characterization of the human B cell stimulatory factor 1 receptor. J Exp Med 1987;166:476-88.
23. Hennino A, Vocanson M, Toussaint Y et al. Skin-infiltrating CD8 + T cells initiate atopic dermatitis lesions. J Immunol 2007;178:5571-7.
24. Hennino A, Jean-Decoster C, Giordano-Labadie F et al. CD8 + T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis. J Allergy Clin Immunol 2011;127:1064-7.
25. Homey B, Alenius H, Muller A et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002;8:157-65.
26. Santulli-Marotto S, Fisher J, Petley T et al. Surrogate antibodies that specifically bind and neutralize CCL17 but not CCL22. Monoclon Antib Immunodiagn Immunother 2013;32:162-71.
27. Wang W, Soto H, Oldham ER et al. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 2000;275:22313-23.
28. Morales J, Homey B, Vicari AP et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999;96:14470-5.
29. Kagami S, Kakinuma T, Saeki H et al. Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. J Invest Dermatol 2005;124:1088-90.
30. Pan J, Kunkel EJ, Gosslar U et al. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol 2000;165:2943-9.
31. Petzelbauer P, Groger M, Kunstfeld R, Petzelbauer E, Wolff K. Human delayed-type hypersensitivity reaction in a SCID mouse engrafted with human T cells and autologous skin. J Invest Dermatol 1996;107:576-81.